BioCorRx (BICX) Other Operating Expenses (2010 - 2026)

BioCorRx has disclosed Other Operating Expenses across 17 years of filings, most recently posting $40143.0 for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $40143.0, up 104.58% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.1 million (up 57.32% YoY), and the FY2025 annual result was -$3.0 million, up 41.6% from the prior year.
• Other Operating Expenses came in at $40143.0 for Q1 2026 at BioCorRx, up from -$342663.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $56951.0 in Q1 2023 to a low of -$1.5 million in Q3 2024.
• The 5-year median for Other Operating Expenses is $1830.0 (2022), against an average of -$472215.2.
• Across the five-year window, Other Operating Expenses surged 3012.08% in 2023 and tumbled 35717.5% in 2024, its largest moves.
• BioCorRx's Other Operating Expenses stood at $8971.0 in 2022, then soared by 48.79% to $13348.0 in 2023, then slumped by 8553.53% to -$1.1 million in 2024, then surged by 69.63% to -$342663.0 in 2025, then surged by 111.72% to $40143.0 in 2026.
• The last three Other Operating Expenses figures came in at $40143.0 (Q1 2026), -$342663.0 (Q4 2025), and -$586370.0 (Q3 2025), per Business Quant data.